Paper81059
Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
Sakamoto N and 3 others. Biochem Pharmacol, 1978. Cited by 84 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator. Papers, record 81059. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/81059
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 3',5'-Cyclic-AMP Phosphodiesterases | Major topic |
| Pyridines | Major topic |
| Vasodilator Agents | Major topic |
| 1-Methyl-3-isobutylxanthine | |
| Animals | |
| Cattle | |
| Coronary Vessels | |
| Cyclic AMP | |
| Dogs | |
| In Vitro Techniques | |
| Kinetics | |
| Male | |
| Myocardium | |
| Nitrobenzenes | |
| Papaverine | |
| Structure-Activity Relationship |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23815532 | A two-for-one bargain: using cilnidipine to treat hypertension and its comorbidities. | J Clin Hypertens (Greenwich) | 2013 | https://conductscience.org/library/papers/23815532 | PubMed |
| 22190992 | In vivo analysis of compound activity and mechanism of action using epistasis in Drosophila. | J Chem Biol | 2011 | https://conductscience.org/library/papers/22190992 | PubMed |
| 7340441 | Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes. | Agents Actions | 1981 | https://conductscience.org/library/papers/7340441 | PubMed |
| 6300912 | Dihydropyridine receptor in rat brain labeled with [3H]nimodipine. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6300912 | PubMed |
| 4027153 | Cardiovascular pharmacology of nicardipine in animals. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4027153 | PubMed |
| 3831015 | Nicardipine releases sustained coronary arterial constriction induced by acetylcholine in the rhesus monkey. | Heart Vessels | 1985 | https://conductscience.org/library/papers/3831015 | PubMed |
| 3297616 | Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. | Drugs | 1987 | https://conductscience.org/library/papers/3297616 | PubMed |
| 1318127 | Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers. | Clin Investig | 1992 | https://conductscience.org/library/papers/1318127 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/81059
GET https://conductscience.org/api/papers/v1/81059/authors